IFNG and neoplasm: IL-18, originally termed IFNγ-inducing factor [18], is considered as a Th1-promoting cytokine since it elicits IFNγ production by T cells, which favors the generation and maintenance of a beneficial inflammatory microenvironment around tumor cells, with potential anti-tumor properties.